Skip to content

Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions.

M E Trulson, A D Stark, B L Jacobs

European Journal of Pharmacology July 15, 1977 DOI: 10.1016/0014-2999(77)90097-8 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Animal experimental study Peer reviewed
Population Rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway
Interventions LSD BOL STP Mescaline DMT 5-M-DMT Tryptamine Scopolamine Psilocin
Dose LSD 0.1 and 0.2 mg/kg; BOL 5 mg/kg; STP 2 and 5 mg/kg; mescaline 50 and 100 mg/kg; DMT 10 and 20 mg/kg; 5-M-DMT 0.75 and 1.25 mg/kg; tryptamine 40 mg/kg; scopolamine 0.25 mg/kg; psilocin 1-20 mg/kg
Measures turning behavior
Key findings LSD produced strong contralateral turning (potent dopamine receptor agonist) and BOL was a weak agonist, while STP and mescaline produced significant ipsilateral turning (moderate dopamine-releasing action). DMT, 5-M-DMT, and psilocin showed weak or no significant turning. The authors propose that serotonin system inactivation may be necessary and sufficient for hallucinogenesis, with dopamine receptor activation possibly influencing hallucinogen potency.

Abstract

The dopaminergic actions of various hallucinogenic drugs were assessed by examining their effects on turning behavior in rats with unilateral 6-hydroxydopamine lesions of the nigro-striatal pathway. LSD (0.1 and 0.2 mg/kg) produced strong contralateral turning, indicating that it is a potent dopamine receptor agonist, while BOL (5 mg/kg), a non-hallucinogenic congener of LSD, was found to be a weak dopamine receptor agonist. STP (2 and 5 mg/kg) and mescaline (50 and 100 mg/kg) produced significant ipsilateral turning, indicating that these compounds have a moderate dopamine-releasing action. DMT (10 and 20 mg/kg) and 5-M-DMT (0.75 and 1.25 mg/kg) produced weak ipsilateral turning, which was not significantly different from that produced by the nonhallucinogenic compounds tryptamine (40 mg/kg) or scopolamine (0.25 mg/kg). Psilocin (1-20 mg/kg) produced no significant turning in either direction. These data, in conjunction with previous studies, indicate that while inactivation of the brain serotonin system may be a necessary and sufficient condition for hallucinogenesis, the ability to activate dopamine receptors may be an important factor in determining the potency of hallucinogens.

Citations in the library

Explore topics